• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Demonstration of specific plasma protein binding sites for somatomedin.

作者信息

Hintz R L, Liu F

出版信息

J Clin Endocrinol Metab. 1977 Nov;45(5):988-95. doi: 10.1210/jcem-45-5-988.

DOI:10.1210/jcem-45-5-988
PMID:925145
Abstract

Native somatomedin (SM) has an apparent mol wt of at least 60,000 daltons, while all the purified SM peptides have mol wt 5-8,000 daltsons. We have studied the behavior of somatomedin in plasma during gel filtration at pH 8.1 and pH 2.8, and by the recombination of fractions. Using porcine bioassay for SM, displacement of 125I-insulin by SM, and binding of 125I-SM to plasma proteins, we can demonstrate that the disparity in apparent mol wt of SM is due to reversible binding to plasma proteins which are themselves biologically inactive. This binding site is specific for the SM peptides, saturable, and has high affinity and relatively low capacity.

摘要

相似文献

1
Demonstration of specific plasma protein binding sites for somatomedin.
J Clin Endocrinol Metab. 1977 Nov;45(5):988-95. doi: 10.1210/jcem-45-5-988.
2
Isolation and partial characterization of six somatomedin-like peptides from human plasma Cohn fraction IV.从人血浆考恩IV组分中分离并部分鉴定六种类生长调节素肽
Acta Endocrinol (Copenh). 1986 Feb;111(2):271-84. doi: 10.1530/acta.0.1110271.
3
Comparison of [125I]somatomedin A and [125I]somatomedin C radioreceptor assays for somatomedin peptide content in whole and acid-chromatographed plasma.
J Clin Endocrinol Metab. 1978 Dec;47(6):1287-95. doi: 10.1210/jcem-47-6-1287.
4
Somatomedin peptide distribution and somatomedin-binding protein content in cord plasma: comparison to normal and hypopituitary plasma.脐血中生长调节素肽分布及生长调节素结合蛋白含量:与正常及垂体功能减退患者血浆的比较
J Clin Endocrinol Metab. 1982 Feb;54(2):223-8. doi: 10.1210/jcem-54-2-223.
5
Ontogeny and characterization of basic somatomedin receptors in rat placenta.
Endocrinology. 1985 Feb;116(2):492-8. doi: 10.1210/endo-116-2-492.
6
Characterization and regulation of a specific cell membrane receptor for somatomedin-C/insulin-like growth factor I in cultured rat granulosa cells.培养的大鼠颗粒细胞中生长调节素C/胰岛素样生长因子I特异性细胞膜受体的特性与调控
Endocrinology. 1988 Jan;122(1):194-201. doi: 10.1210/endo-122-1-194.
7
Somatomedin inhibitor in uremia.尿毒症中的生长调节素抑制剂。
J Clin Endocrinol Metab. 1984 Oct;59(4):764-72. doi: 10.1210/jcem-59-4-764.
8
Isolation of a somatomedin from plasma of rats bearing growth hormone secreting tumors.从患有生长激素分泌肿瘤的大鼠血浆中分离出一种生长调节素。
Endocrinology. 1977 Feb;100(2):549-56. doi: 10.1210/endo-100-2-549.
9
Isolation of a somatomedin-binding protein from preterm amniotic fluid. Development of a radioimmunoassay.从早产羊水分离生长调节素结合蛋白。放射免疫分析法的开发。
J Clin Endocrinol Metab. 1984 Nov;59(5):899-907. doi: 10.1210/jcem-59-5-899.
10
Liberation of immunoreactive somatomedin-C from its binding proteins by proteolytic enzymes and heparin.通过蛋白水解酶和肝素从其结合蛋白中释放免疫反应性生长调节素C。
J Clin Endocrinol Metab. 1983 Feb;56(2):384-9. doi: 10.1210/jcem-56-2-384.

引用本文的文献

1
IGFBP-2 and IGF-II: Key Components of the Neural Stem Cell Niche? Implications for Glioblastoma Pathogenesis.胰岛素样生长因子结合蛋白-2与胰岛素样生长因子-II:神经干细胞生态位的关键组成部分?对胶质母细胞瘤发病机制的影响
Int J Mol Sci. 2025 May 15;26(10):4749. doi: 10.3390/ijms26104749.
2
Endocrine and cellular physiology and pathology of the insulin-like growth factor acid-labile subunit.胰岛素样生长因子酸不稳定亚基的内分泌和细胞生理学及病理学。
Nat Rev Endocrinol. 2024 Jul;20(7):414-425. doi: 10.1038/s41574-024-00970-4. Epub 2024 Mar 21.
3
Pregnancy-Associated Plasma Protein (PAPP)-A2 in Physiology and Disease.
妊娠相关血浆蛋白 A2(PAPP-A2)在生理学和疾病中的作用。
Cells. 2021 Dec 18;10(12):3576. doi: 10.3390/cells10123576.
4
Insulin-like growth factors: Ligands, binding proteins, and receptors.胰岛素样生长因子:配体、结合蛋白和受体。
Mol Metab. 2021 Oct;52:101245. doi: 10.1016/j.molmet.2021.101245. Epub 2021 May 4.
5
Insulin-like growth factor system in cancer: novel targeted therapies.癌症中的胰岛素样生长因子系统:新型靶向疗法。
Biomed Res Int. 2015;2015:538019. doi: 10.1155/2015/538019. Epub 2015 Mar 19.
6
IGFBPs and neoplastic models. New concepts for roles of IGFBPs in regulation of cancer cell growth.胰岛素样生长因子结合蛋白(IGFBPs)与肿瘤模型。IGFBPs在调节癌细胞生长中作用的新概念。
Endocrine. 1997 Aug;7(1):111-3. doi: 10.1007/BF02778076.
7
Insulin-like growth factor-I and insulin-like growth factor-binding proteins in the nephrotic syndrome.
Pediatr Nephrol. 1996 Jun;10(3):355-8. doi: 10.1007/BF00866783.
8
Hormonal and radiological effects of megavoltage radiotherapy in patients with growth hormone-secreting pituitary adenoma.生长激素分泌型垂体腺瘤患者接受兆伏级放疗后的激素及影像学效应
J Endocrinol Invest. 1993 Sep;16(8):565-72. doi: 10.1007/BF03347671.
9
Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults.重组人胰岛素样生长因子-I与胰岛素代谢效应的比较。健康青年和中年成年人的剂量反应关系。
J Clin Invest. 1994 Mar;93(3):1131-9. doi: 10.1172/JCI117065.
10
Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein.通过与增殖刺激活性的载体蛋白结合来抑制其生物活性。
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7252-6. doi: 10.1073/pnas.77.12.7252.